BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3485584)

  • 21. Combination of trimethoprim with sulfonamides other than sulfamethoxazole.
    Bernstein LS
    Rev Infect Dis; 1982; 4(2):411-8. PubMed ID: 7051239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
    Nouws JF; Firth EC; Vree TB; Baakman M
    Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and body fluid and endometrial concentrations of trimethoprim-sulfamethoxazole in mares.
    Brown MP; Gronwall R; Castro L
    Am J Vet Res; 1988 Jun; 49(6):918-22. PubMed ID: 3261143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and clinical experiences of sulfadiazine in low doses alone and in combination with trimethoprim.
    Seppänen J
    Ann Clin Res; 1980; (25):4-18. PubMed ID: 7377749
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacokinetic studies with the combination sulfamoxole/trimethoprim in animals and men (author's transl)].
    Kuhne J; Kohlmann FW; Seydel JK; Wempe E
    Arzneimittelforschung; 1976; 26(42):651-7. PubMed ID: 947326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of the combined preparation trimezole--Farmakhim. II. Comparative pharmacokinetic studies of trimezole and biseptol in healthy volunteers].
    Mikhaĭlova D; Mikhaĭlova S; Bogoslovova T; Prodanova K; Raĭnova L
    Eksp Med Morfol; 1986; 25(1):13-20. PubMed ID: 3488900
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative pharmacokinetics of co-trifamole and co-trimoxazole to 'steady state' in normal subjects.
    Watson ID; Cohen HN; Stewart MJ; McIntosh SJ; Shenkin A; Thomson JA
    Br J Clin Pharmacol; 1982 Sep; 14(3):437-43. PubMed ID: 6982055
    [No Abstract]   [Full Text] [Related]  

  • 28. Coptin (sulphadiazine + trimethoprim).
    Drug Ther Bull; 1979 Dec; 17(25):97-9. PubMed ID: 397044
    [No Abstract]   [Full Text] [Related]  

  • 29. Trimethoprim-sulfamethoxazole compared with sulfamethoxazole in urinary tract infection.
    Lemieux G
    Can Med Assoc J; 1974 Apr; 110(8):910-2. PubMed ID: 4596406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic progress: trimethoprim-sulfamethoxazole.
    Ruiz López R; Saavedra S; Ramírez-Ronda CH
    Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.
    Bergan T; Brodwall EK; Vik-Mo H; Anstad U
    Infection; 1979; 7 Suppl 4():S382-7. PubMed ID: 511352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Choice of treatment in recurrent urinary infections in childhood].
    Sánchez Bayle M; Barrio Pérez ML; Estepa Soto MR; López Verde L
    An Esp Pediatr; 1984 Jan; 20(1):28-32. PubMed ID: 6608301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderly.
    Varoquaux O; Lajoie D; Gobert C; Cordonnier P; Ducreuzet C; Pays M; Advenier C
    Br J Clin Pharmacol; 1985 Dec; 20(6):575-81. PubMed ID: 3879182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of urinary tract infections with pipemidic acid and cotrimoxazol. A comparative study].
    Schüller J; Walther V; Mayer P; Marx FJ
    MMW Munch Med Wochenschr; 1983 May; 125(20):427-30. PubMed ID: 6410191
    [No Abstract]   [Full Text] [Related]  

  • 35. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection.
    Nguyen HT; Hurwitz RS; Defoor WR; Minevich E; McAdam AJ; Mortensen JE; Novak-Weekley SM; Minnillo BJ; Elder JS
    J Urol; 2010 Jul; 184(1):305-10. PubMed ID: 20488468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them].
    Busk HE; Korner B; Hammer R
    Ugeskr Laeger; 1985 Nov; 147(48):3895-7. PubMed ID: 3878615
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides.
    Ortengren B; Fellner H; Bergan T
    Infection; 1979; 7 Suppl 4():S367-70. PubMed ID: 511350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
    Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG;
    Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.
    Aarbakke J; Opshaug O; Digranes A; Høylandskjaer A; Fluge G; Fellner H
    Eur J Clin Pharmacol; 1983; 24(2):267-71. PubMed ID: 6840178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diffusion of the drug combination sulfamethoxazole-trimethoprim. Microdetermination in the perilymph, blood and urine of subjects with otosclerosis].
    Jacob M; Causse J; Gaudy D; Duru C; Causse JB; Puech A
    Pharm Acta Helv; 1982; 57(3):93-6. PubMed ID: 6978490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.